findmyKOL

Farahnaz Joarder, MD

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNone on fileNPI
RegionLa Jolla, CA · WestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Farahnaz Joarder is an Endocrinology/Metabolic physician. OpenAlex indexes 26 publications with 598 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
26publications

Distinct works indexed by OpenAlex.

598citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

10666 N Torrey Pines Rd
Ms212a
La Jolla, CA 920371027

Telephone

858-554-7876

Registry record last updated 22 Jun 2009.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    88.3%
    Insulin Analog42.4%
    Lantus Solostar15%Tresiba Flextouch U-10012%Humalog10%Novolog Flexpen10%Basaglar Kwikpen U-1008%Humalog Kwikpen U-1006%Insulin Aspart Flexpen6%Toujeo Solostar6%Insulin Lispro Kwikpen U-1005%Insulin Lispro5%Lantus5%Novolog5%Fiasp Flextouch4%Admelog Solostar3%Toujeo Max Solostar3%
    Part D<11 patients
    GLP-1 receptor agonist22.1%
    Ozempic61%Trulicity33%Mounjaro6%
    Part D<11 patients

    + 4 more classes in this area

  • Hormonal (systemic)

    5.9%
    l-Thyroxine4%
    Levothyroxine Sodium100%
    Part D<11 patients
    Antihypoglycemic Agent1.9%
    Baqsimi100%
    Part D14 patients
  • Cardiovascular

    5.8%
    Statin3.6%
    Atorvastatin Calcium67%Rosuvastatin Calcium33%
    Part D<11 patients
    ACE inhibitor1.1%
    Lisinopril100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)66.5% facility · 33.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”